Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Capital One Financial Co.

EyePoint Pharmaceuticals Inc.
Start price
€18.40
11.12.23 / 50%
Target price
€40.94
11.12.24
Performance (%)
-56.86%
End price
€7.94
12.12.24
Summary
This prediction ended on 12.12.24 with a price of €7.94. The BUY prediction by Capital_One_Financia for EyePoint Pharmaceuticals Inc. performed very badly with a performance of -56.86%. Capital_One_Financia has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
EyePoint Pharmaceuticals Inc. -7.339% -7.339% 19.273%
iShares Core DAX® 2,57 % 5,33 % 8,27 %
iShares Nasdaq 100 4,86 % 0,45 % 27,08 %
iShares Nikkei 225® 5,59 % -0,59 % 48,55 %
iShares S&P 500 3,25 % 2,50 % 23,35 %

Comments by Capital_One_Financia for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -56.86%
Target price 40.938
Change
Ends at 11.12.24

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $44.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Capital One Financial Co. 
0
Report Share
11.12.23
In the thread Trading EyePoint Pharmaceuticals Inc.
Prediction Buy
Perf. (%) -56.86%
Target price 40.938
Change
Ends at 11.12.24

Die von Capital_One_Financia gewählte maximale Laufzeit wurde überschritten

Capital One Financial Co. 
0
Report Share
12.12.24